|
02 Apr 2021 |
Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
|
|
02 Apr 2021 |
AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
|
|
02 Apr 2021 |
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
|
|
30 Mar 2021 |
Leiden University Medical Center and Ixaka enter collaboration to strengthen knowledge of cell therapy candidate REX-001
|
|
30 Mar 2021 |
Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP)
|
|
30 Mar 2021 |
BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for "Undruggable" Targets
|
|
22 Mar 2021 |
SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche
|
|
18 Mar 2021 |
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs
|
|
17 Mar 2021 |
Amathus Therapeutics Signs Strategic Collaboration With Merck to Develop Treatments for Neurodegenerative Diseases
|
|
17 Mar 2021 |
Seekyo raises over €650,000 from business angels and Bpifrance
|
|
17 Mar 2021 |
DZNE and Eisai enter into research collaboration agreement aiming for novel drug discovery for neurodegenerative disorders
|
|
16 Mar 2021 |
GBT Expands Sickle Cell Disease Pipeline with Exclusive In-license of Two Novel Small Molecule Programs from Sanofi S.A.
|
|
16 Mar 2021 |
Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders
|
|
16 Mar 2021 |
Boehringer Ingelheim and The Lieber Institute for Brain Development to Collaborate to Develop Centrally Acting COMT Inhibitors for Treatment of Neuropsychiatric Disorders
|
|
15 Mar 2021 |
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis
|
|
11 Mar 2021 |
Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins
|
|
09 Mar 2021 |
Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
|
|
09 Mar 2021 |
Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
|
|
05 Mar 2021 |
ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
|
|
02 Mar 2021 |
Mitokinin, Inc., Enters into Purchase Right Agreement with AbbVie
|
|
02 Mar 2021 |
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
|
|
01 Mar 2021 |
Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
|
|
01 Mar 2021 |
Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
|
|
01 Mar 2021 |
HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration
|
|
25 Feb 2021 |
Merck to Acquire Pandion Therapeutics
|
